Follow

BiVictriX Therapeutics Plc

London AIM (United Kingdom)

BiVictriX is a UK based drug development company which has developed its proprietary Bi-Cygni® technology. This technology utilises Antibody Drug Conjugates ("ADC"s), an existing class of potent biological drugs, for the treatment of various cancers including Acute Myeloid Leukaemia, the first condition which BVX intends to treat.

Sector:
HEALTH CARE
 
News
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
London AIM
United Kingdom (GB)
Details of share in BiVictriX Therapeutics Plc with ticker
Status
Inactive
Amount of instruments
Currency
GBP
Type
Price
Pre-money
Time
Files
Listing
Aug 2021
Direct listing of BiVictriX Therapeutics Plc on London AIM
People
Tiffany Jane Thorn
CEO
Iain Gladstone Ross
Chairman of the board
Robert Edward Hawkins
Board member
Susan Day Lowther
Board member
William Drummond Paris
Board member
Company Details
Sector
HEALTH CARE

Address
86 Deansgate
Zip code
M3 2ER
City/district
Manchester
Country
United Kingdom (GB)
Phones
Registration number
10005270
LEI code
First trade date
Registration date
15 Feb 2016
Short name
BiVictriX

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More